MIRA INFORM REPORT

 

 

Report Date :

21.01.2008

 

IDENTIFICATION DETAILS

 

Name :

ENCUBE ETHICALS PRIVATE LIMITED

 

 

Registered Office :

Unit No. 24, Steelmade Industrial Estate, Marol, Andheri (East), Mumbai – 400 059, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

07.09.1985

 

 

Com. Reg. No.:

11-92485

 

 

CIN No.:

[Company Identification No.]

U24230MH1995PTC092485

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUME02391E

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing and Importing of Dermatological Pharmaceutical and Therapeutic Preparation, Patent Medicines, Drugs, etc.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 660000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established and reputed company having fine track. Directors are reported as experienced and respectable businessmen. Trade relations are fair. Business is active. Payments are reported as usually correct and as per commitments.

 

The company can be considered good for normal business dealings at usual trade terms and conditions. 

 

 

LOCATIONS

 

Registered Office :

Unit No. 24, Steelmade Industrial Estate, Marol, Andheri (East), Mumbai – 400 059, Maharashtra, India

Tel. No.:

91-22-56783848 (3 Lines) / 28503838 / 28504335 / 28508612

Fax No.:

91-22-28504336

E-Mail :

encube@bom3.vsnl.net.in

encube.mumbai@encubeethicals.com 

mehul.shah@encubeethicals.com

Website :

http://www.encubeethicals.com

 

 

Factory :

Plot No. C-1, Madkaim Industrial Estate, Madkaim, Post : Mardol, Ponda, Goa – 403 404

Tel. No.:

91-832-2392223/2392314

Fax No.:

91-832-2392225

E-Mail :

encube@sancharnet.in

prashant.j@encubeethicals.com

 

 

DIRECTORS

 

Name :

Mr. Mehul Shah

Designation :

Managing Director

Address :

Flat 501 / 52B Apartment, 7th NS Road, JVPD Scheme, Vile Parle [West], Mumbai – 400049, Maharashtra, India 

Date of Birth/Age :

21.07.1966

Date of Appointment :

07.09.1995

 

 

Name :

Mr. Madhusudan M. Shah

Designation :

Director

Address :

Flat 501 / 52B Apartment, 7th NS Road, JVPD Scheme, Vile Parle [West], Mumbai – 400049, Maharashtra, India 

Date of Birth/Age :

30.11.1934

Date of Appointment :

07.09.1995

 

 

Name :

Mr. Himanshu M Gandhi

Designation :

Director

Address :

B 301 Gokul Gagan Dattani Park, Kandivali [East], Mumbai – 400101, Maharashtra, India

Date of Birth/Age :

23.01.1970

Date of Appointment :

30.01.2002

 

 

Name :

Mr. Nilesh N Maniar

Designation :

Director

Address :

1 Ashish 51 C, S V Road, Santacruz West, Mumbai – 400054, Maharashtra, India

Date of Birth/Age :

06.07.1960

Date of Appointment :

30.01.2002

Date of Ceasing :

30.08.2002

 

 

KEY EXECUTIVES

 

Name :

Mr. Prashant Jain

Designation :

Plant Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

Names of Shareholders

 

No. of Shares

Mehul Shah

 

600000

Madhusudan M. Shah

 

600000

G Shah

 

20

Nilesh N Maniar

 

20

Rupa Maniar

 

20

Chandramani Maniar

 

20

Chandra Shah

 

225000

Himanshu M Gandhi

 

20

Niti Shah

 

74910

Pinki Gandhi

 

20

Total

 

1500030

 

 

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and Importing of Dermatological Pharmaceutical and Therapeutic Preparation, Patent Medicines, Drugs, etc.

 

 

Products :

Dermatological Pharmaceutical and Therapeutic Preparation, Patent Medicines, Drugs, etc.

 

 

Exports :

 

Countries :

Japan

 

PRODUCTION STATUS

 

Particulars

Unit

Installed Capacity

Non Sterile Ointments

 

Single Shift

960.000

Non Sterile Ointments :-

 

 

Sales

Single Shift

211.10

Labour

Single Shift

351.84

 

 

GENERAL INFORMATION

 

Customers :

  • Galderma (India) Private Limited
  • Micro Labs Limited
  • Brown and Burk Pharmaceutical Limited
  • Aventis Pharma Limited
  • Unimark Remedies Limited
  • Okasa Private Limited
  • Zuventus Healthcare Limited
  • Nicholas Piramal Limited
  • Sandoz Private Limited
  • Sanofi-Synthelabo

 

 

No. of Employees :

180

 

 

Bankers :

  • Janakalyan Saharaki Bank Limited, Mumbai, Maharashtra
  • Small Industrial Development Bank of India, New Horizone, 1st Floor, St. Mary’s Colony, Dayanand Bandodkar Marg, Miramar, Panji – 403001, Goa, India
  • ICICI Bank Limited, 1st Floor, Sagar Avenue, Opposite Shopper Stop, Andheri [West], Mumbai – 400053, Maharashtra, India

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

Shaparia & Mehta

Chartered Accountants

Address :

1/74, Krishna Kunj, R. A. Kidwani Road, King Cercle, Mantunga, Mumbai – 400019, Maharashtra, India

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

25,00,000

Equity Shares

Rs. 10/-  each

Rs. 25.000 millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

15,00,030

Equity Shares

Rs. 10/-  each

Rs. 15.000 millions

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2007

31.03.2006

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

15.000

15.000

2] Share Application Money

 

0.000

0.000

3] Reserves & Surplus

 

149.255

129.726

4] (Accumulated Losses)

 

0.000

0.000

NETWORTH

 

164.255

144.726

LOAN FUNDS

 

 

 

1] Secured Loans

 

34.664

10.176

2] Unsecured Loans

 

60.500

0.100

TOTAL BORROWING

 

95.164

10.276

DEFERRED TAX LIABILITIES

 

12.129

12.114

 

 

 

 

TOTAL

 

271.548

167.116

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

95.907

77.261

Capital work-in-progress

 

77.816

1.824

 

 

 

 

INVESTMENT

 

0.100

0.100

DEFERREX TAX ASSETS

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

20.465

11.534

 

Sundry Debtors

 

35.308

22.135

 

Cash & Bank Balances

 

37.969

53.660

 

Other Current Assets

 

0.000

0.000

 

Loans & Advances

 

95.985

63.437

Total Current Assets

 

189.727

150.766

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

 

47.864

22.586

 

Provisions

 

44.138

40.257

Total Current Liabilities

 

92.002

62.843

Net Current Assets

 

97.725

87.923

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.000

0.008

 

 

 

 

TOTAL

 

271.548

167.116

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2007

31.03.2006

Debt Equity Ratio

(Total Liability/Networth)

 

 

1.14

0.51

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

2.06

2.40

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Bankers Charges Report as per Registry

 

 

Name of the company

ENCUBE ETHICALS PRIVATE LIMITED

Presented By

Mr. Madhusudan M. Shah, Director

1) Date and description of instrument creating the change

Deed of Hypothecated the 10th day of October, 2005 executed by Encube Ethicals Private Limited [therein and hereinafter referred to as the Borrower in favour of ICICI Bank Limited]

2) Amount secured by the charge/amount owing on the securities of charge

Secured working capital facilities not exceeding Rs. 20.000 Millions

4) Gist of the terms and conditions and extent and operation of the charge.

In Consideration of ICICI having granted / agreed to grant to the borrower the facilities, agreement and declaration by the borrower, inter alia as follows :

 

Covenant by the borrower to comply / to ensure compliance with all the terms and conditions set out in Master facility agreement dated 10th October 2005 entered between the Borrower and ICICI, as modified amended/ renewed / supplemented from time to time.

 

The borrower shall pay all amount in respect of the facilities and pay interest and all other monies in the manner set out in the agreement and the other Transaction Documents.

 

The assets were thereby hypothecated inter alia to ICICI as and by way of first charge, as security for and be charged with the repayment of the facilities, all interest and other monies payable by the Borrower to ICICI as specified in the agreement and the other Transaction Documents.

 

The Borrower to keep the Assets in marketable and good condition and also insured as provided in the Deed of Hypothecation / the agreement.

 

Power of Entry, power to take charge and / or possession of, seize, recover, receive, appoint receiver of and remove and / or sale by auction or private contract, dispatch for realization or otherwise dispose of or deal with all or any part of the Assets etc. as provided in the Deed of Hypothecation.

 

All other terms and conditions as contained in the Deed of Hypothecation.

5) Name and Address and description of the person entitled to the charge.

ICICI Bank Limited, 1st Floor, Sagar Avenue, Opposite Shopper Stop, Andheri [West], Mumbai – 400053, Maharashtra, India

6) Date  and brief description of instrument modifying the charge

NA

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

NA

 

 

This form is for

Modification of charge

Charge identification number of the charge to be modified

10037554

Corporate identity number of the company

U24230MH1995PTC092485

Name of the company

ENCUBE ETHICALS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Unit No. 24, Steelmade Industrial Estate, Marol, Andheri (East), Mumbai – 400 059, Maharashtra, India

Type of charge

Immovable Property

Particular of charge holder

Small Industrial Development Bank of India, New Horizone, 1st Floor, St. Mary’s Colony, Dayanand Bandodkar Marg, Miramar, Panji – 403001, Goa, India

satyakir@sidbi.in

Nature of description of the instrument creating or modifying the charge

Declaration and undertaking in the matter of a mortgage by deposit of title deeds dated 12.02.2007

Date of instrument Creating the charge

12.02.2007

Amount secured by the charge

Rs. 30.000 Millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest :

10 % p.a. on principal amount of the loan outstanding, from time to time on 1st of every month additional interest of 1 % in company fails to create securities as stated in article III within stipulated time

 

Extent and operation of the charge :

Charge to cover all outstanding dues and interest

Short particulars of the property charged

Hypothecation of plant, equipment, machinery spares, tools, accessories and all other assets proposed to be acquired under the scheme. Hypothecation of all borrower’s movable including the movables, plant, machinery, tools and accessories, office equipments, computers, furniture and fixture at Plot No. D1, D2, D3 and D 15, Madkaim Industrial estate, Madkaim, Ponda, Goa subject to prior charges created and to be created.

Particulars of the present modification 

First modification :

 

Additional security provided by deposit of title deed for mortgage of immovable property situated at  Plot No. D1, D2, D3 and D 15, Madkaim Industrial estate, Madkaim, Ponda, Goa

 

All other terms and conditions of original charge remain unchanged.

 

 

FIXED ASSETS

 

 

AS PER WEBSITE

 

Subject is a progressive CONTRACT MANUFACTURING company dedicated to the topical preparations viz. Creams, Ointments, Gels, Lotions and Solutions.


The state of the art plant of subject was commissioned in Goa in March 1998. The facility is approved by international regulatory health authorities like Health Products and Food Branch Inspectorate (HPFBI)-Canada and TGA- Australia. Also the facility is holding WHO-GMP certificate, ISO 9001 : 2000 certification and IDMA Quality Excellence Gold Award for the year 2004.

 

This is possibly the only facility in India exclusively devoted to Dermatology, manufacturing a range of Products as follows :

 

 

Green land with a variety of trees has a passion that runs parallel to the business growth. They have set up their plant amidst the serene surroundings of picturesque Goa, while their Registered office is in Mumbai the financial capital of the nation.

 

The existing Plant is admeasuring  4300 Sq Mt. of built up area , built on an area of 35000 Sq.Mt of land.

 

Salient Features of existing plant

 

 

Product Range

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.39.38

UK Pound

1

Rs.76.90

Euro

1

Rs.57.27

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

63

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions